Clinical Trial Update: Methylphenidate Study in Young Children With Developmental Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial of methylphenidate in young children with developmental disorders (ADHD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: University of Arizona | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED